JANUARY 9, 2020
Grants Awarded 

Extramurally funded research grants awarded to Rogel Cancer Center Members

Program Key:
CB- Cancer Biology; CG- Cancer Genetics; CHI- Cancer Hematopoiesis and Immunology; DT- Developmental Therapeutics; HBO- Health Behavior and Outcomes; CEP- Cancer Epidemiology and Prevention; TACR- Translational and Clinical Research
$100K+ Grants Awarded in December
Jolanta Grembecka, Ph.D. : R01 ($2.8M) "Development of ASH1L inhibitors for acute leukemia" (DT)

Sarah Hawley, Ph.D., MPH and Reshma Jagsi, M.D., D.Phil. : R01 ($2.1M) "Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (ShaDES)" (HBO)

Ganesh Palapattu, M.D. and Arun Sreekumar, Ph.D. (Baylor): R01 ($101K) "Metabolic rewiring promotes AA PCa by regulating stromal-epithelial interaction" (TACR)

Stephen Weiss, M.D. : R01 renewal ($1.9M) "Function of Membrane Type Matrix Metalloproteinase" (CB)
Other NIH
Lana Garmire, Ph.D. : NLM R01 ($1M) "DR. EPS: Drug Repurposing for Extended Patient Survival" (CG)
Other External
Chan Chung (mentor: Sriram Venneti, M.D., Ph.D. ): $148K from the Michael Mosier Defeat DIPG Foundation and ChadTough Foundation for "Targeting DIPGs by interrupting metabolic pathways" (CG)

Carl Koschmann, M.D. : $158K from The Cure Starts Now Foundation for "Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG" (TACR)

Gabriel Nunez, M.D. : $673K from Millennium Pharmaceuticals, Inc. for "Development of a Model to Study Checkpoint Inhibitor-Associated Colitis" (CHI)

Greg Thurber, Ph.D. : $139K from Immunomedics for "Pre-clinical sacituzumab govitecan in vivo (imaging/flow) and Dye-linker experiments" (DT)
Please forward this message to your fellow cancer center colleagues.
M-LINE 800-962-3555 | BLOG michiganhealthlab.org